Despite being one of the fastest-growing demographic groups in the U.S., Hispanic individuals remain significantly underrepresented in clinical trials. This gap not only limits the generalizability of research findings, but also deepens existing healthcare disparities. In this whitepaper, we explore real perspectives from Hispanic patients across two different healthcare settings, examining their awareness of clinical trials, the barriers they face, and what factors influence their willingnes ...

FOMAT Medical Research, a leader in advancing diversity in clinical trials, announces a new partnership with Dr. Daniel R. Agarwal, an ophthalmologist specializing in retina and vitreous care, based at San Luis Obispo Eye Associates. This collaboration highlights FOMAT’s commitment to expanding its expertise into ophthalmology and retina-focused clinical trials, enhancing access to innovative therapies in Central California. Dr. Agarwal, a distinguished graduate of Weill Cornell Medicine, bri ...

OXNARD, CA, UNITED STATES, December 30, 2024  FOMAT Medical Research has opened a new operational hub in Santa Maria, California, further advancing its mission to bring clinical research opportunities to underserved communities. Building on years of active research in the area, this strategic expansion enhances FOMAT’s ability to provide cutting-edge treatment options while addressing critical healthcare disparities. This initiative aligns with the organization’s commitment to expanding access t ...

Oxnard, California, December 17, 2024 – FOMAT Medical Research, an industry leader in fostering diversity in clinical research, has partnered with Golden Valley Health Centers (GVHC), one of the largest nonprofit healthcare providers in Central and Northern California, to offer clinical trial opportunities and advanced treatment options to underserved communities. This alliance will bring innovative clinical research directly to over 160,000 patients across Merced, Stanislaus, and San Joaquin co ...

FOMAT Medical Research has earned the prestigious 2024 Excellence in Patient Centricity Award from the Society for Clinical Research Sites (SCRS). Sponsored by Sanofi, this award recognizes clinical research sites that put patient experience at the heart of their operations. FOMAT’s innovative use of technology to enhance patient engagement and recruitment stood out, showcasing their commitment to making the clinical trial process more accessible, inclusive, and patient-centered. Leading the Wa ...

The Ventura County Biotech Trade Delegation recently concluded a significant mission to India, strengthening ties between Ventura County’s biotech sector and India’s fast-growing biotechnology market. Led by Ventura County Supervisor Jeff Gorell and organized with Brent Reinke, Founder of the BioScience Alliance, the mission was supported by key stakeholders, including the U.S. Commercial Service and the Economic Development Collaborative (EDC). This initiative marks a new chapter in fostering c ...

FOMAT Medical Research has expanded its research portfolio by launching a new oncology research unit at its headquarters in Oxnard, California. This initiative brings community-based oncology clinical trials to Ventura and surrounding counties, offering patients local access to innovative cancer treatments. By integrating oncology into its therapeutic offerings, FOMAT aims to accelerate the development of advanced cancer therapies, particularly those that address the unique needs of diverse popu ...

FOMAT Medical Research has announced an important partnership with four medical groups in Santa Maria, CA. This collaboration, involving Central Coast Retina, Jeffrey Kaplan MD Pediatric Medicine Inc., Comprehensive Cardiovascular Care, and Central Coast Family Care, will create a clinical trial hub that offers local patients access to innovative treatments across ophthalmology, pediatrics, cardiology, and family medicine. This partnership aligns with FOMAT’s mission to diversify and expand c ...